Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
about
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathEffects of PPARα inhibition in head and neck paraganglioma cellsPPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growthA Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In VivoValproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro modelPPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop.Regulation of IL-8 gene expression in gliomas by microRNA miR-93.Localization of PPAR isotypes in the adult mouse and human brain.Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines.Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry.Metabolomics and Metabolic Reprogramming in Kidney Cancer.Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.Translating Metabolic Reprogramming into New Targets for Kidney Cancer
P2860
Q28080874-627E2E8A-C525-4849-B818-DB7F169EA072Q33779008-7E77C9A6-6168-45D2-BEBC-91E62F1F76BCQ35671904-1FEC278D-29E7-42E4-8621-6F68D3073988Q36025695-8527D45D-C6C9-47D9-AA4F-9FCFB34F6448Q37441534-EF5B4622-1B92-441C-8A9B-46C241F6F14AQ37708993-694AAB5A-5295-433D-85A1-878900CB53A0Q38829417-75EE49E7-E0BA-48DF-902A-F0D91C872009Q42735293-DBB6856D-5FE0-4F96-8DBF-F6032000205EQ43974650-ABC31D31-4434-40F7-8D26-BA205FF011D0Q47390152-5AD40CC2-3FC1-4371-A237-E397B4C08F42Q48350605-8FC3E7B9-E1D2-4957-AA74-9B086D57664EQ49678727-98F40A05-9C19-4660-84B7-F2CC986F128CQ51038667-588BD1D2-A780-4921-817D-8BD19709A0B1Q52618376-90128045-4A67-4F21-814A-A3A5A287D3BFQ55454154-EF94F0F9-DC40-4BDE-8E11-602D6DDE1B68Q58585088-20767D78-E267-42EE-BF3F-6C07FE988261
P2860
Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@ast
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@en
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@nl
type
label
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@ast
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@en
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@nl
prefLabel
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@ast
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@en
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@nl
P2093
P2860
P1433
P1476
Inhibition of PPARα induces ce ...... bition in kidney cancer cells.
@en
P2093
Hiromi I Wettersten
Omran Abu Aboud
Robert H Weiss
P2860
P304
P356
10.1371/JOURNAL.PONE.0071115
P407
P577
2013-08-07T00:00:00Z